The 3 analysts offering 12-month price forecasts for Eloxx Pharmaceuticals Inc have a median target of 1.50, with a high estimate of 4.00 and a low estimate of 0.50. The median estimate represents a +442.69% increase from the last price of 0.28.
The current consensus among 3 polled investment analysts is to Buy stock in Eloxx Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.10
Reporting Date Aug 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.